These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 20397815)

  • 21. Efficacy and safety of roflumilast in the treatment of asthma.
    Bateman ED; Izquierdo JL; Harnest U; Hofbauer P; Magyar P; Schmid-Wirlitsch C; Leichtl S; Bredenbröker D
    Ann Allergy Asthma Immunol; 2006 May; 96(5):679-86. PubMed ID: 16729780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T
    Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel trends in pharmacotherapy of chronic obstructive pulmonary disease--prevention of exacerbations (focus on roflumilast)].
    Sinopal'nikov AI
    Klin Med (Mosk); 2014; 92(2):57-64. PubMed ID: 25269184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roflumilast in chronic obstructive pulmonary disease: evidence from large trials.
    Cazzola M; Picciolo S; Matera MG
    Expert Opin Pharmacother; 2010 Feb; 11(3):441-9. PubMed ID: 20102307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roflumilast in the management of chronic obstructive pulmonary disease.
    Lipari M; Benipal H; Kale-Pradhan P
    Am J Health Syst Pharm; 2013 Dec; 70(23):2087-95. PubMed ID: 24249758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roflumilast for severe COPD?
    Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of roflumilast in patients with stable chronic obstructive pulmonary disease: a meta-analysis.
    Yan JH; Gu WJ; Pan L
    Pulm Pharmacol Ther; 2014 Feb; 27(1):83-9. PubMed ID: 23624309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Considerations for Roflumilast: A New Treatment for COPD.
    Kelly Freeman ML
    Consult Pharm; 2012 Mar; 27(3):189-93. PubMed ID: 22421519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New drugs in chronic obstructive pulmonary disease].
    Chazan RC
    Pneumonol Alergol Pol; 2011; 79(3):232-8. PubMed ID: 21509737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lipworth BJ
    Lancet; 2005 Jan 8-14; 365(9454):167-75. PubMed ID: 15639300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Calzetta L; Rogliani P; Matera MG
    Expert Opin Drug Discov; 2016 Jul; 11(7):733-44. PubMed ID: 27169612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease.
    Rabe KF
    Br J Pharmacol; 2011 May; 163(1):53-67. PubMed ID: 21232047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roflumilast: systemic therapy for chronic obstructive pulmonary disease.
    McIvor RA
    Expert Rev Respir Med; 2008 Oct; 2(5):539-49. PubMed ID: 20477289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma.
    Field SK
    Expert Opin Investig Drugs; 2008 May; 17(5):811-8. PubMed ID: 18447606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

  • 38. Roflumilast added to triple therapy in patients with severe COPD: a real life study.
    Muñoz-Esquerre M; Diez-Ferrer M; Montón C; Pomares X; López-Sánchez M; Huertas D; Manresa F; Dorca J; Santos S
    Pulm Pharmacol Ther; 2015 Feb; 30():16-21. PubMed ID: 25445930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial.
    Rabe KF; Bateman ED; O'Donnell D; Witte S; Bredenbröker D; Bethke TD
    Lancet; 2005 Aug 13-19; 366(9485):563-71. PubMed ID: 16099292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.